$36.4 Million is the total value of Virtus ETF Advisers LLC's 76 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MMP | New | MAGELLAN MIDSTREAM PRTNRS LP | $2,874,000 | – | 42,311 | +100.0% | 7.89% | – |
ETP | New | ENERGY TRANSFER PRTNRS L Pcall | $1,855,000 | – | 55,000 | +100.0% | 5.09% | – |
BPL | New | BUCKEYE PARTNERS L Punit ltd partn | $1,642,000 | – | 24,889 | +100.0% | 4.51% | – |
WMB | New | WILLIAMS COS INC DEL | $1,640,000 | – | 63,805 | +100.0% | 4.50% | – |
EPD | New | ENTERPRISE PRODS PARTNERS L | $1,426,000 | – | 55,762 | +100.0% | 3.91% | – |
WMB | New | WILLIAMS COS INC DELcall | $1,157,000 | – | 45,000 | +100.0% | 3.18% | – |
EPD | New | ENTERPRISE PRODS PARTNERS Lcall | $1,151,000 | – | 45,000 | +100.0% | 3.16% | – |
OMER | New | OMEROS CORP | $696,000 | – | 44,237 | +100.0% | 1.91% | – |
KERX | New | KERYX BIOPHARMACEUTICALS INC | $689,000 | – | 136,472 | +100.0% | 1.89% | – |
WES | New | WESTERN GAS PARTNERS LP | $680,000 | – | 14,300 | +100.0% | 1.87% | – |
AEGR | New | AEGERION PHARMACEUTICALS INC | $656,000 | – | 64,959 | +100.0% | 1.80% | – |
SGEN | New | SEATTLE GENETICS INC | $653,000 | – | 14,541 | +100.0% | 1.79% | – |
IONS | New | IONIS PHARMACEUTICALS INC | $647,000 | – | 10,447 | +100.0% | 1.78% | – |
NKTR | New | NEKTAR THERAPEUTICS | $645,000 | – | 38,260 | +100.0% | 1.77% | – |
PGNX | New | PROGENICS PHARMACEUTICALS IN | $636,000 | – | 103,807 | +100.0% | 1.75% | – |
VNDA | New | VANDA PHARMACEUTICALS INC | $624,000 | – | 67,021 | +100.0% | 1.71% | – |
ARNA | New | ARENA PHARMACEUTICALS INC | $614,000 | – | 323,107 | +100.0% | 1.68% | – |
ALXN | New | ALEXION PHARMACEUTICALS INC | $604,000 | – | 3,167 | +100.0% | 1.66% | – |
GEL | New | GENESIS ENERGY L Punit ltd partn | $598,000 | – | 16,278 | +100.0% | 1.64% | – |
AMGN | New | AMGEN INC | $592,000 | – | 3,644 | +100.0% | 1.62% | – |
PSXP | New | PHILLIPS 66 PARTNERS LP | $588,000 | – | 9,581 | +100.0% | 1.61% | – |
GILD | New | GILEAD SCIENCES INC | $588,000 | – | 5,810 | +100.0% | 1.61% | – |
CELG | New | CELGENE CORP | $585,000 | – | 4,884 | +100.0% | 1.61% | – |
ANAC | New | ANACOR PHARMACEUTICALS INC | $581,000 | – | 5,147 | +100.0% | 1.60% | – |
MDCO | New | MEDICINES CO | $572,000 | – | 15,331 | +100.0% | 1.57% | – |
PAA | New | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $571,000 | – | 24,737 | +100.0% | 1.57% | – |
RTRX | New | RETROPHIN INC | $552,000 | – | 28,634 | +100.0% | 1.52% | – |
SE | New | SPECTRA ENERGY CORP | $422,000 | – | 17,608 | +100.0% | 1.16% | – |
CEQP | New | CRESTWOOD EQUITY PARTNERS LPunit ltd partner | $407,000 | – | 19,580 | +100.0% | 1.12% | – |
PAA | New | PLAINS ALL AMERN PIPELINE Lcall | $347,000 | – | 15,000 | +100.0% | 0.95% | – |
ADXS | New | ADVAXIS INC | $334,000 | – | 33,234 | +100.0% | 0.92% | – |
ATRA | New | ATARA BIOTHERAPEUTICS INC | $321,000 | – | 12,137 | +100.0% | 0.88% | – |
BLCM | New | BELLICUM PHARMACEUTICALS INC | $306,000 | – | 15,086 | +100.0% | 0.84% | – |
RXDX | New | IGNYTA INC | $303,000 | – | 22,638 | +100.0% | 0.83% | – |
PRTK | New | PARATEK PHARMACEUTICALS INC | $300,000 | – | 15,819 | +100.0% | 0.82% | – |
OPHT | New | OPHTHOTECH CORP | $293,000 | – | 3,735 | +100.0% | 0.80% | – |
CARA | New | CARA THERAPEUTICS INC | $292,000 | – | 17,299 | +100.0% | 0.80% | – |
ARWR | New | ARROWHEAD RESH CORP | $292,000 | – | 47,549 | +100.0% | 0.80% | – |
GERN | New | GERON CORP | $288,000 | – | 59,436 | +100.0% | 0.79% | – |
PTLA | New | PORTOLA PHARMACEUTICALS INC | $286,000 | – | 5,561 | +100.0% | 0.78% | – |
INSM | New | INSMED INC | $285,000 | – | 15,716 | +100.0% | 0.78% | – |
SRE | New | SEMPRA ENERGY | $284,000 | – | 3,017 | +100.0% | 0.78% | – |
IMMU | New | IMMUNOMEDICS INC | $284,000 | – | 92,480 | +100.0% | 0.78% | – |
SGMO | New | SANGAMO BIOSCIENCES INC | $282,000 | – | 30,847 | +100.0% | 0.77% | – |
CLVS | New | CLOVIS ONCOLOGY INC | $280,000 | – | 7,999 | +100.0% | 0.77% | – |
ACAD | New | ACADIA PHARMACEUTICALS INC | $279,000 | – | 7,814 | +100.0% | 0.77% | – |
SRPT | New | SAREPTA THERAPEUTICS INC | $278,000 | – | 7,203 | +100.0% | 0.76% | – |
RLYP | New | RELYPSA INC | $278,000 | – | 9,802 | +100.0% | 0.76% | – |
LJPC | New | LA JOLLA PHARMACEUTICAL CO | $277,000 | – | 10,250 | +100.0% | 0.76% | – |
MGNX | New | MACROGENICS INC | $276,000 | – | 8,911 | +100.0% | 0.76% | – |
ONTY | New | ONCOTHYREON INC | $275,000 | – | 123,925 | +100.0% | 0.76% | – |
NVAX | New | NOVAVAX INC | $274,000 | – | 32,714 | +100.0% | 0.75% | – |
LXRX | New | LEXICON PHARMACEUTICALS INC | $273,000 | – | 20,486 | +100.0% | 0.75% | – |
TSRO | New | TESARO INC | $273,000 | – | 5,210 | +100.0% | 0.75% | – |
NLNK | New | NEWLINK GENETICS CORP | $272,000 | – | 7,484 | +100.0% | 0.75% | – |
TRVN | New | TREVENA INC | $268,000 | – | 25,478 | +100.0% | 0.74% | – |
RDUS | New | RADIUS HEALTH INC | $267,000 | – | 4,345 | +100.0% | 0.73% | – |
MACK | New | MERRIMACK PHARMACEUTICALS IN | $265,000 | – | 33,570 | +100.0% | 0.73% | – |
LOXO | New | LOXO ONCOLOGY INC | $263,000 | – | 9,258 | +100.0% | 0.72% | – |
SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $261,000 | – | 46,043 | +100.0% | 0.72% | – |
DTE | New | DTE ENERGY CO | $260,000 | – | 3,248 | +100.0% | 0.71% | – |
ALDR | New | ALDER BIOPHARMACEUTICALS INC | $255,000 | – | 7,728 | +100.0% | 0.70% | – |
CNCE | New | CONCERT PHARMACEUTICALS INC | $255,000 | – | 13,456 | +100.0% | 0.70% | – |
DVAX | New | DYNAVAX TECHNOLOGIES CORP | $251,000 | – | 10,380 | +100.0% | 0.69% | – |
ARDX | New | ARDELYX INC | $249,000 | – | 13,717 | +100.0% | 0.68% | – |
EIX | New | EDISON INTL | $242,000 | – | 4,091 | +100.0% | 0.66% | – |
AWK | New | AMERICAN WTR WKS CO INC NEW | $186,000 | – | 3,112 | +100.0% | 0.51% | – |
ITC | New | ITC HLDGS CORP | $180,000 | – | 4,598 | +100.0% | 0.49% | – |
CMS | New | CMS ENERGY CORP | $173,000 | – | 4,802 | +100.0% | 0.48% | – |
ATO | New | ATMOS ENERGY CORP | $167,000 | – | 2,651 | +100.0% | 0.46% | – |
PNW | New | PINNACLE WEST CAP CORP | $118,000 | – | 1,836 | +100.0% | 0.32% | – |
AEP | New | AMERICAN ELEC PWR INC | $117,000 | – | 2,012 | +100.0% | 0.32% | – |
POR | New | PORTLAND GEN ELEC CO | $77,000 | – | 2,105 | +100.0% | 0.21% | – |
SO | New | SOUTHERN CO | $39,000 | – | 837 | +100.0% | 0.11% | – |
OKE | New | ONEOK INC NEW | $33,000 | – | 1,356 | +100.0% | 0.09% | – |
SHLX | New | SHELL MIDSTREAM PARTNERS L Punit ltd int | $29,000 | – | 689 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
INCYTE CORP | 31 | Q3 2023 | 2.1% |
ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
EXELIXIS INC | 31 | Q3 2023 | 1.8% |
VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-15 |
13F-HR | 2023-11-07 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.